Cambria Investment Management, L.P. Harmony Biosciences Holdings, Inc. Transaction History
Cambria Investment Management, L.P.
- $1.59 Billion
- Q3 2024
A detailed history of Cambria Investment Management, L.P. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cambria Investment Management, L.P. holds 331,551 shares of HRMY stock, worth $11.4 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
331,551Holding current value
$11.4 Million% of portfolio
0.83%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
243Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$387 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$120 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$89.9 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$66.5 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.04B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...